Product Catalog


Influenza A H1N1 Neuraminidase / NA (Active)
| Catalog | Size (Price) | Quantity | In Stock | Operation | Other Information |
| 11058-V07HC |
|
YES |
|
![]() |
|
H1N1 NA / Neuraminidase Protein Datasheet
H1N1 NA Protein Price Inquiry ( Available Sizes )
- Bulk: Inquiring Price
H1N1 NA Protein Product Information
| Synonym : |
NA |
| Protein Construction: |
A DNA sequence encoding the Influenza A virus (A/California/04/2009 (H1N1)) neuraminidase (ACP41107.1) (His 36-Lys 469) was expressed, the cell lysates are collected, and bio-activity was tested |
| Source: | Influenza A Virus H1N1 |
| Expression Host: | Human Cells |
H1N1 NA Protein QC Testing
|
Bio-activity: |
Measured by its ability to cleave a fluorogenic substrate, 2'-(4-Methylumbelliferyl)-α-D-N-acetylneuraminic acid The specific activity is > 600 U One unit is defined as the amount of enzyme required to cleave 1 nmole of 2'-(4-Methylumbelliferyl)-α-D-N-acetylneuraminic acid per minute at pH 7.5 at 37℃. |
| Endotoxin: | < 1.0 EU per μg of the protein as determined by the LAL method |
| Stability: | Samples are stable for up to twelve months from date of receipt at -70℃ |
| Molecular Mass: | The influenza H1N1 virus Neuraminidase comprises 450 amino acids |
| Formulation: | Lyophilized from PBS, 0.6% Triton X-100, 7% Trehalose, 6% Mannitol, pH7.4 Please contact us for any concerns or special requirements. |
H1N1 NA Protein Usage Guide
| Storage: | Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles. |
| Reconstitution: | It is recommended that 1 ml sterile water be added to the vial to prepare a stock solution. |
H1N1 NA Protein Related Products & Topics
Related Areas:
Enzyme>>Carbohydrate Metabolism Enzymes>>H1N1 neuraminidase/H1N1 NA
Immunology>>Innate Immunity>>Lysosomal Enzyme>>H1N1 neuraminidase/H1N1 NA
Virus>>Influenza Virus>>H1N1 neuraminidase/H1N1 NA
Proteins:
| Products | Source (CLICK for detailed Info. and Price) | Molecule | Description | Cat. No |
| Protein | Influenza Neuraminidase (NA) H1N1, A/California/04/2009 |
NA | Fc Tag | 11058-V01H |
| Protein | Influenza Neuraminidase (NA) H1N1, A/California/04/2009 |
NA | His Tag | 11058-V07H |
| Protein | Influenza Neuraminidase (NA) H1N1, A/California/04/2009 ![]() |
NA | His Tag | 11058-V07B |
| Protein | Influenza Neuraminidase (NA) H1N1, A/California/04/2009 ![]() |
NA | His Tag | 11058-V07HC |
| Protein | Influenza Neuraminidase (NA) H1N1, A/California/04/2009 ![]() |
NA | - | 11058-VNAHC |
| Protein | Influenza Neuraminidase (NA) H1N1, A/California/04/2009 ![]() |
NA | - | 11058-VNAHC1 |
Antibodies:
| Products | Antigen Source (CLICK for detailed Info. and Price) |
Antigen Molecule |
Application | Cat No |
| MAb | Influenza Antibody to H1N1, Mouse Anti H1N1 MAb |
NA | WB, ELISA | 11058-MM04 |
Related Influenza Virus Research Tools
H1N1 NA Protein Description
Neuraminidase (NA) and hemagglutinin (HA) are major membrane glycoproteins found on the surface of influenza virus. NA, also called sialidases, specifically catalyze the hydrolysis removal of terminal sialic acid residues from viral and cellular glycoconjugates. It is known that HA binds to the sialic acid-containing receptors on the surface of host cells during initial infection, and at the end of an infectious cycle, NA cleaves the HA-sialic acid bondage from the newly formed virions and the host cell receptors during budding. NA is described as a receptor-destroying enzyme which facilitates virus release and efficient spread of the progeny virus from cell to cell. NA is a single-pass type I I membrane protein which exists as a homotetramer, and the transmembrane domain is involved in lipid raft association during intracellular transport. NA is suggested to play a role in the determination of host range restriction on replication and virulence. Nine subtypes of NA have been identified, and subtypes N1 and N2 have been positively linked to epidemics in man.
References
- Barman, S. et al., 2000, J. Virol. 74: 6538-6545.
- Colman, PM. et al., 1983, Nature. 303: 41-44.
- Suzuki, T. et al., 2005, J. Virol. 79: 11705-11715.
- von, Itzstein, M. 2007, Nat. Rev. Drug. Discov. 6: 967-974.
+86-400-890-9989






